Inventor
SCHACHTEL BERNARD
US22 patents
⚠️ This page may combine multiple inventors who share the name “SCHACHTEL BERNARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LOCL PHARMA INC
11 patentsUS10064856B2Sep 4, 2018
Pharmaceutical compositions
LOCL PHARMA INC25 citations97
US9226901B2Jan 5, 2016
Pharmaceutical compositions
LOCL PHARMA INC18 citations92
US9526704B2Dec 27, 2016
Pharmaceutical compositions for treating or preventing pain
LOCL PHARMA INC5 citations83
US9433625B2Sep 6, 2016
Pharmaceutical compositions for treating or preventing pain
LOCL PHARMA INC6 citations83
US10016368B2Jul 10, 2018
Pharmaceutical compositions for treating or preventing pain
LOCL PHARMA INC3 citations72
US9855264B2Jan 2, 2018
Pharmaceutical compositions
LOCL PHARMA INC2 citations72
US9789104B2Oct 17, 2017
Pharmaceutical compositions
LOCL PHARMA INC1 citations62
US9387177B2Jul 12, 2016
Pharmaceutical compositions
LOCL PHARMA INC2 citations62
US10532030B2Jan 14, 2020
Pharmaceutical compositions for treating or preventing pain
LOCL PHARMA INC0 citations51
US9789105B2Oct 17, 2017
Pharmaceutical compositions
LOCL PHARMA INC0 citations51
US9498444B2Nov 22, 2016
Pharmaceutical compositions
LOCL PHARMA INC0 citations51
SCHABAR RES ASSOCIATES LLC
5 patentsUS12053457B2Aug 6, 2024
Unit oral dose compositions composed of ibuprofen and famotidine for the treatment of acute pain and the reduction of the severity and/or risk of heartburn
SCHABAR RES ASSOCIATES LLC2 citations72
US11331307B2May 17, 2022
Unit oral dose compositions composed of ibuprofen and famotidine for the treatment of acute pain and the reduction of the severity and/or risk of heartburn
SCHABAR RES ASSOCIATES LLC4 citations72
US12048690B2Jul 30, 2024
Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity and/or risk of heartburn
SCHABAR RES ASSOCIATES LLC0 citations61
US11324727B2May 10, 2022
Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn
SCHABAR RES ASSOCIATES LLC0 citations61
US12514846B2Jan 6, 2026
Unit oral dose compositions composed of ibuprofen or a pharmaceutically acceptable salt thereof and famotidine or a pharmaceutically acceptable salt thereof for the treatment of acute pain and the reduction of the severity and/or risk of heartburn and/or upset stomach
SCHABAR RES ASSOCIATES LLC0 citations51
BOSSE PAUL
3 patentsCHARLESTON LABORATORIES INC
3 patentsUS9775837B2Oct 3, 2017
Pharmaceutical compositions
CHARLESTON LABORATORIES INC2 citations82
US10179109B2Jan 15, 2019
Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates
CHARLESTON LABORATORIES INC7 citations80
US10772840B2Sep 15, 2020
Sumatriptan promethazine pharmaceutical compositions
CHARLESTON LABORATORIES INC0 citations48